Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.L. Ribeiro
The Novel Bispecific Cd47-Cd19 Antibody Tg-1801 Potentiates the Activity of Ublituximab-Umbralisib (U2) Drug Combination in Preclinical Models of B-NHL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Plasma Hydroxy-Metronidazole/ Metronidazole Ratio in Hepatitis C Virus-Induced Liver Disease
Brazilian Journal of Medical and Biological Research
Immunology
Cell Biology
Pharmacology
Biochemistry
Biophysics
Neuroscience
Medicine
Toxicology
Physiology
Pharmaceutics
Related publications
Phase I/Ii Study of Umbralisib (Tgr-1202) in Combination With Ublituximab (Tg-1101) and Pembrolizumab in Patients With Rel/Ref CLL and Richter's Transformation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anti-Cd47 Agent Boosts Macrophage Activity in NHL
Cancer Discovery
Oncology
Tolerability and Activity of Chemo-Free Triplet Combination of TGR-1202, Ublituximab, and Ibrutinib in Patients With Advanced CLL and NHL.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Synergistic Antitumor Effect of Bispecific CD19 X CD3 and CD19 X CD16 Diabodies in a Preclinical Model of Non-Hodgkin's Lymphoma
Journal of Immunology
Allergy
Immunology
Targeting a Membrane-Proximal Epitope on Mesothelin Increases the Tumoricidal Activity of a Bispecific Antibody Blocking CD47 on Mesothelin-Positive Tumors
mAbs
Allergy
Immunology
Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Curaxin CBL0137 Eradicates Drug Resistant Cancer Stem Cells and Potentiates Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Oncotarget
Oncology
